BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Merck
Baxter
Moodys
Deloitte
Fish and Richardson
Accenture
McKesson
Julphar
McKinsey

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,664,215

« Back to Dashboard

Summary for Patent: 8,664,215
Title:Ocular allergy treatments with alcaftadine
Abstract: Compositions, kits, and methods for the treatment or prevention of ocular allergies and inflammation and the symptoms thereof containing alcaftadine or a pharmaceutically acceptable salt thereof.
Inventor(s): Ingerman; Avner (Scarsdale, NY), Janssens; Frans (Bonheiden, BE), Megens; Anton (Beerse, BE), Abelson; Mark B. (Andover, MA)
Assignee: Vistakon Pharmaceuticals, LLC (Jacksonville, FL)
Application Number:11/690,954
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 8,664,215

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Allergan LASTACAFT alcaftadine SOLUTION/DROPS;OPHTHALMIC 022134-001 Jul 28, 2010 RX Yes Yes ➤ Subscribe ➤ Subscribe METHOD FOR PREVENTING ITCHING ASSOCIATED WITH ALLERGIC CONJUNCTIVITIS ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,664,215

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 101460176 ➤ Subscribe
Costa Rica 10414 ➤ Subscribe
Denmark 2004196 ➤ Subscribe
Eurasian Patent Organization 200870396 ➤ Subscribe
Eurasian Patent Organization 016221 ➤ Subscribe
Ecuador SP088786 ➤ Subscribe
Spain 2594655 ➤ Subscribe
European Patent Office 2004196 ➤ Subscribe
European Patent Office 3150209 ➤ Subscribe
Hong Kong 1131331 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Citi
Covington
Queensland Health
Deloitte
Baxter
Boehringer Ingelheim
Chubb
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot